North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Oppenheimer assumed coverage on shares of Abbott Laboratories in a report on Tuesday, October 8th. They set an “outperform” rating and a $130.00 price objective on the stock. Piper Sandler ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Abbott is expected to post earnings of $1.07 ...

During this period, the Zacks Medical - Products industry, which Abbott falls in, has gained 9.7%. The key question now is: What could be the stock's future direction? While media releases or rumors ...

Mizuho raised their price objective on Abbott Laboratories from $115.00 to $130.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Argus raised shares of ...

Let's delve deeper into each type of owner of Abbott Laboratories ... to see a big share price drop if two large institutional investors try to sell out of a stock at the same time.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...